Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

WEHI study reveals new methods in detecting necroptosis

Fully automated diagnostic techniques, including liquid handling robots, are poised to improve the lives of millions of people living with inflammatory diseases worldwide.

24 Jun 2024

Study shows high burden of arthritis symptoms in patients people with psoriasis

Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients – 25% of the total studied so far.

22 Jun 2024

Transforming care for rheumatoid arthritis patients through symptom monitoring

Researchers at The University of Manchester are to trial a system that allows people living with rheumatoid arthritis to send their daily symptoms securely to their health record, in a first for the NHS.

22 Jun 2024

EULAR updates PRP guidelines: Enhancing patient involvement in rheumatic disease research

In recent years, the benefits of involving PRPs has increasing been recognized. The role is an important one, which goes well beyond the inclusion of patients as study participants.

18 Jun 2024

Understanding salivary gland microenvironment to advance Sjögren's disease treatment

TLS are accumulations of lymphoid cells that share similar cellular compartments, organization, and function as secondary lymphoid organs. Importantly, the presence of these structures in inflamed salivary glands associated with active disease, increased autoantibody production, and malignancy risk.

16 Jun 2024

Long-term benefits of plant-based diet and lifestyle intervention in RA patients

The 16-week Plants for Joints trial investigated the effects of a multidisciplinary lifestyle intervention in people with RA, as compared to usual care.

16 Jun 2024

New EULAR survey: Patients across Europe invited to share RMD experiences

EULAR's new survey seeks to gather valuable insights from patients across Europe on the impact of rheumatic and musculoskeletal diseases (RMDs).

14 Jun 2024

EULAR endorses self-management of inflammatory arthritis with RECLARIT

EULAR - The European Alliance of Associations for Rheumatology - recommends patient self-management for people with inflammatory arthritis.

14 Jun 2024

EULAR unveils ambitious 2024-2029 European Manifesto to combat rheumatic diseases

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of its 2024 - 2029 European Manifesto, aimed at addressing the urgent need for a coordinated European response to Rheumatic and Musculoskeletal Diseases (RMDs), focusing particularly on the areas of quality of care, research, and social policy.

14 Jun 2024

EULAR launches ENTRI initiative to boost rheumatic disease research across Europe

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of the EULAR Network of TRIal Centres (ENTRI) initiative.

14 Jun 2024

Blood interferon signature reveals key differences in pediatric-onset Sjögren's disease

Due to differences in clinical presentation and limited knowledge, diagnosing Sjögren's disease in children can be challenging.

14 Jun 2024

New insights into predictors of organ damage in childhood-onset SLE

Childhood-onset systemic lupus erythematosus (cSLE) is a chronic, severe autoimmune disorder that carries a risk of early organ damage.

14 Jun 2024

Tackling challenges in childhood arthritis transition to adult care

Rheumatological diseases can affect people during childhood, the most common being juvenile idiopathic arthritis (JIA).

14 Jun 2024

Exploring the comorbidities associated with osteoarthritis

Osteoarthritis is the most common arthritis worldwide, and has an increasing global burden of disability and healthcare utilization.

14 Jun 2024

Mutated TREX1 gene linked to catastrophic DNA damage and deadly rare disease

TREX1 is a gene that is supposed to direct the maintenance of the entire body's DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy (RVCL).

13 Jun 2024

New insights into physical activity adoption for rheumatic patients

An HPR abstract sessions at the 2024 EULAR congress looked specifically at harnessing the benefits of exercise in rheumatic and musculoskeletal diseases (RMD) – and the challenges to their practical implementation.

13 Jun 2024

Dose reduction of glucocorticoids in systemic lupus erythematosus

Glucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals.

13 Jun 2024

New insights into blood precursors of pathogenic macrophages in RA

The exact origin and precursor differentiation route of tissue macrophages remains controversial. At the 2024 congress of EULAR - The European Alliance of Associations for Rheumatology - new work sheds light on blood precursors of pathogenic tissue macrophages.

13 Jun 2024

Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis

Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR - The European Alliance of Associations for Rheumatology - recommends early intervention in arthritis, since conventional synthetic disease-modifying antirheumatic drugs (csDMARD) have been shown to slow disease progression in both rheumatoid and psoriatic arthritis.

13 Jun 2024

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

Scientists at Weill Cornell Medicine discovered a previously unknown link between two key pathways that regulate the immune system in mammals-;a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD).

12 Jun 2024